Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MT-CO1 | P00395 | 1/20 | 0.47 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MC4R | P32245 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3246285 | 0.83 | PTGS2 (0.51) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| SCHEMBL2349058 | 0.74 | CA12 (0.66) | PTGS2PTGS1KDM4ECYP2C19 | |
| SCHEMBL7617599 | 0.72 | PTGS2 (0.64) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| SCHEMBL34837 | 0.72 | CA2 (0.61) | PTGS2TSHRCYP2C19 | |
| SCHEMBL8985490 | 0.72 | PTGS2 (0.67) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| SCHEMBL8985304 | 0.72 | PTGS2 (0.55) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| SCHEMBL8985337 | 0.71 | PTGS2 (0.52) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| Hydrochloric Acid SCHEMBL11213950 | 0.71 | CA2 (0.59) | PTGS2TSHRCYP2C19 | |
| SCHEMBL8985205 | 0.69 | PTGS2 (0.55) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| SCHEMBL3199738 | 0.69 | LMNA (0.54) | PTGS2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1390026-B1 | TREATMENT OF HPV CAUSED DISEASES | CORNELL RES FOUNDATION INC (US) | 2010-05-05 | — | — | EP | claimed |